jaybe points out that the '788 potential pool is already under a bit of pressure, just as was '113 in EGFR, i.e. more dose needed, AE's a potentially larger problem than in the primary target.
The BoD overpaid themselves and the CEO, they breached their fiduciary responsibilities, they doctored their records and coerced and bought off their accuser...I want THE TRUTH!!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.